Belarusian Ministry of Health Grants Registration to Cuban Vaccine Cimavax

Minsk, July 12 (RHC) The Ministry of Health of the Republic of Belarus reports that the Center for Expertise and Testing in Health Care has granted registration to the Cuban vaccine Cimavax, it was learned here today.

Developed by the Cuban Center for Molecular Immunology, it is the world's first officially patented and registered therapeutic vaccine against lung cancer.

The Cuban Ambassador to the Slavic nation, Santiago Pérez, commented that the decision of the regulatory agency of this European country to grant registration to Cimavax is an undeniable achievement of Cuban biotechnology in a country with such high standards and requirements as Belarus.

Pérez recalled that Belarus was the first country on the continent to register the Cuban vaccine Soberana, developed against Covid-19.

The Cuban diplomat said the registration is a sign of progress in bilateral relations, especially in the economic-commercial field, which would allow an increase in Cuba's exports.

Likewise, it shows the progress made in cooperation between the scientific communities of the two countries, and perhaps it is the beginning of a more dynamic process of mutual registration of medicines both in Belarus and Cuba, said Perez. (Source: PL)